There will always be competitors (hence why Phillips hasn't exclusive chosen PCK to participate). Same with the following which seems to be years behind and I am not sure whether blood analysis of these biomarkers is quick or not (usually blood sample takes a lot longer than using an algorithm an diagnosis).
In the medical industry, it's the initial "brand" that is released to the market first which allows it to establish it's market and "loyalty".
https://www.sciencedaily.com/releases/2019/02/190213142715.htm
PainChek General Discussion, page-7529
-
- There are more pages in this discussion • 12,884 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
